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Table S1. Geographic prevalence studies separated into CiHHV-6A and CiHHV-6B. 






Cord blood USA (NY) 5638 [19 *] 12 (0.2) [38 *] 25 (0.4) (Hall et al., 2008, 2004) 
Blood donor-adult USA (Texas) 100 0 (<1.0) 1 (1.0) (Hudnall et al., 2008) 
Blood donor Canada (Ontario) 288 0 (<0.3) 0 (<0.3) (Gravel et al., 2013) 
Blood donors-adult France 200 0 (<0.5) 1 (0.5) (Geraudie et al., 2012) 
Blood donor–adult UK (London) 500 0 (<0.2) 4 (0.8) (Leong et al., 2007) 
Serum bank-child UK 610 4 + (0.7) 6 + (1.0) (Ward et al., 2005) 
Blood controls UK (Northern) 563 1 (0.2) 10 (1.7) (Bell et al., 2014) ^ 





495 0 (<0.2) 0 (<0.2) # 
Region Totals 
North America N 6026 12 (0.2) 26 (0.4)  
Europe E 2582 6 (0.2)  24 (0.9)  
Donor Total NA + E 8608 18 (0.2) 50 (0.6)  
Patients
SOT-Liver  USA 548 1 (0.2) 6 (1.1) (Lee et al., 2012) 
SOT-Kidney USA 46 0 (<2.0) 1 (2.2) (Lee et al., 2011) 
Leukemic children Canada (Ontario) 287 1 (0.3) 0 (<0.3) (Gravel et al., 2013) 
SOT-mixed. Blood, tissue, hair 
samples 
Italy 135 1 (0.7) 0 (<0.8) (Potenza et al., 2009) 
SCT-Blood, hair samples Italy 70 0 (<1.4) 1 (1.4) (Potenza et al., 2009) 
CSF-encephalitis referral 
child/adult UK 522 1 (0.2) 5 (1.0) (Ward et al., 2007) 
Hodgkins lymphoma UK (Northern) 936 1 (0.1) 15 (1.6) (Bell et al., 2014) ^ 
Cardiac referrals Germany 3610 7 (0.2) 13 (0.4) (Tweedy et al., 2015) 
Malignant disease-blood Czech Republic 812 7 (0.9) 2 (0.2) (Hubacek et al., 2013) 
Leukemia-child-blood Czech Republic 339 4 (1.2) 1 (0.3) (Hubacek et al., 2009) 
Transplant donors/recipients-
blood, herpesvirus referrals 
Japan (Osaka) 2332 1 (0.04) 4 (0.2) (Tanaka-Taya et al., 
2004) 








73 0 (<1%) 1 (1.2%) (Faten et al., 2012) 
Region Totals 
North America 881 2 (0.2) 7 (0.8)  
Europe 6424 21 (0.3) 37 (0.6)  
Japan, J 2332 1 (0.04) 4 (0.2)  
Patient Total NA + E + J + A 9719 23 (0.3) 34 (0.4)  
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Table S1. Cont. 








North America 6907 14 (0.2) 33 (0.5)  
Europe  9006 27 (0.3) 61 (0.7)  
Japan 2332 1 (0.04)  4 (0.2)   
Africa, A 868 0 (<0.1) 1 (0.1)  
ALL NA + E + J + A 19,113 41 (0.2) 74 (0.4)  
* Original numbers screened, then those positively identified listed next; +4 and 6 positively 
identified; SOT—solid organ transplantation recipients; CSF—cerebral spinal fluid; NA North 
America; # Musonda, K. and Gompels, U.A., Analyses congenital infections with betaherpesviruses 
in Zambia, unpublished; manuscript in preparation; ^ References [1,15] type by polymerase gene, 
which HHV-6A variation may confound [4,16]. 
Table S2. HHV-6A SNPs detected in CiHHV-6A by deep sequencing. 
No. 
SNPs U54 HHV-6A > CiHHV-6A SNPs U54 Amino Acid 
HHV-6A 
U1102 
% HHV-6A Minor Variant 
SNPs in CiHHV-6A 
HHV-6A:U1102, GS & AJ Changes Position 2284 5055 5814
1 A > G - 86,106 < < < 
2 A > G - 86,142 17 < < 
3 G > A (AJ only) - 86,195 17 < < 
4 A > G (AJ only) I > T 86,329 16 < < 
5 G > T (AJ only) L > I 86,372 16 < < 
6 T > C [S, A, T > M] 86,379 17 < < 
7 G > A [S, A, T > M] 86,380 18 < < 
8 C (U1102) A (GS) > T S, A, T > M 86,381 < < < 
9 T > C T > A 86,387 16 < < 
10 G > C - 86,400 17 < < 
11 T > C (GS only) - 86,514 14 < < 
12 T > C T > A 86,537 30 < 4 
13 G > T T > N 86,608 31 < < 
14 A > G  - 86,613 31 < < 
15 A > G  - 86,619 31 < < 
16 C > A  V > F 86,627 30 < < 
17 G > A  - 86,638 28 < < 
18 G > A P > S 86,645 25 < < 
19 A > G - 86,720 17 < < 
20 T > A (GS only) - 86,724 < < < 
21 G > T A > D 86,761 16 < < 
22 A > C [I, L > R] 86,791 17 < < 
23 T > G (GS only) I, L > R 86,792 < < < 
24 T > C (AJ only) N > D 86,801 17 < < 
25 G > T (U1102) K, N > I 86,811 < < < 
26 T > A [K, N > I] 86,812 16 < < 
27 A > G - 86,859 14 < < 
28 T > C N > D 86,891 19 < < 
29 C > G (U1102 only) G > A 86,893 < < < 
30 G > T T > N 86,896 19 < < 
31 C > T (U1102 only) - 86,943 < < < 
32 A > C (GS only) N > K 86,949 < < < 
33 G > T (U1102 only) Q > K 87,011 < < < 
34 T > C K > R 87,016 22 < < 
35 A > G - 87,036 21 < < 
36 C > T A > T 87,092 16 < < 
37 C > T (U1102 and AJ) R > H 87,100 16 < < 
38 A > G (GS only) S > P 87,110 < < < 
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Table S1. Cont. 
No. 




% HHV-6A Minor Variant 
SNPs in CiHHV-6A 
HHV-6A:U1102, GS & AJ Changes Position 2284 5055 5814
39 C > A (GS only) A > S 87,119 < < < 
40 T > C (GS only) M > V 87,128 < < < 
41 G > C N > K 87,129 20 < < 
42 G > A H > Y 87,137 19 < < 
43 T > G R > S 87,171 18 < < 
44 A > T I > N 87,199 18 < 2 
45 C > A Q > R 87,204 18 < < 
46 T > C Q > R 87,205 18 < 3 
47 T > C T > A 87,266 15 < < 
48 A > G I > T 87,289 15 < < 
49 T > C (GS) - 87,299 < < < 
50 A > G (U1102 and AJ) S > P 87,308 15 < < 
51 A > G (GS) S > P 87,314 < < < 
Mean read depths from new sequences from this study (methods 2.3) were for endogenous CiHHV-
6A genomes from patients 2284, 5055 and 5814 it was 314, 9943 and 8941 respectively. Comparisons 
were made to all available reference genomes, from exogenous HHV-6A strains U1102, GS and AJ 
(methods 2.2). SNP% cutoffs were <0.5% reads indicated by <. Coding from the opposite strand. 





Figure S1. (a) Structure of CiHHV-6A/B underlined as integrated into the sub-telomeric region of 
human chromosomes. DR-L is the left direct repeat and DR-R is the right direct repeat in the 
prototype orientation of the virus genome, and bound the unique region, U, encoding most coding 
sequences; (b) The structure of the DR region from HHV-6A/B which includes the pac 1 and pac 2 
DNA packaging signals, imperfect telomeric repeat region T1, perfect telomeric repeat region T2, 
and spliced coding sequences for genes DR1 and DR6. In the CiHHV-6A/B genomes the DR regions 
do not have the terminal pac sites. 
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